基于“态靶理论”探讨放射性食管炎的治疗策略
Exploring Treatment Strategies for Radiation Esophagitis Based on the “Status-Target Theory”
DOI: 10.12677/tcm.2025.1412789, PDF,    科研立项经费支持
作者: 张万翼, 祝朝富*:成都中医药大学附属医院,四川 成都
关键词: 态靶理论放射性食管炎噎膈Status-Target Theory Radiation Esophagitis Dysphagia
摘要: 放射性食管炎是胸部恶性肿瘤放疗后常见的并发症之一,治疗难度大、效果不甚理想。目前中医对放射性食管炎的发生发展及变化规律正在逐步深化,但临床上仍以对症治疗为主。本文基于仝小林院士的“态靶辨治”体系和中医对放射性食管炎的认识,重新对疾病进行分类、辨态、识靶。辨治放射性食管炎辨以“热、毒、瘀、虚”四态;识“吞咽困难、恶心、呃逆、胸骨后刺痛”之症靶;“白细胞介素-6、内镜下黏膜损伤分级”之标靶。治疗以“清热、解毒、补虚、化瘀”为主。文章通过初步构建放射性食管炎的态靶辨治体系,为提高放射性食管炎治疗效果提供新的临床思路。
Abstract: Radiation esophagitis is one of the common complications following radiotherapy for thoracic malignancies, and it is difficult to treat with poor outcomes. Currently, traditional Chinese medicine (TCM) is gradually deepening its understanding of the occurrence, development, and progression of radiation esophagitis, with clinical treatment mainly focused on symptom management. This article, based on Academician Tong Xiaolin’s “status-target differentiation and treatment” system and TCM’s understanding of radiation esophagitis, reclassifies, differentiates, and identifies the disease. Radiation esophagitis is differentiated according to four states: “heat, toxin, stasis, and deficiency”; symptoms are identified as targets including “difficulty swallowing, nausea, hiccups, and retrosternal stabbing pain”; and markers are identified as “interleukin-6 and endoscopic mucosal injury grading”. Treatment mainly focuses on “clearing heat, detoxifying, tonifying deficiency, and resolving stasis”. By preliminarily establishing a status-target differentiation and treatment system for radiation esophagitis, this article provides new clinical ideas to improve treatment effectiveness.
文章引用:张万翼, 祝朝富. 基于“态靶理论”探讨放射性食管炎的治疗策略[J]. 中医学, 2025, 14(12): 5497-5501. https://doi.org/10.12677/tcm.2025.1412789

参考文献

[1] Xu, Y., Dong, B., Zhu, W., Li, J., Huang, R., Sun, Z., et al. (2022) A Phase III Multicenter Randomized Clinical Trial of 60 Gy versus 50 Gy Radiation Dose in Concurrent Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma. Clinical Cancer Research, 28, 1792-1799. [Google Scholar] [CrossRef] [PubMed]
[2] 乔金飞, 齐小玉, 伍荣庭, 等. 基于“瘤毒-态靶”理论辨治胰腺癌[J]. 中医药临床杂志, 2024, 36(11): 2049-2052.
[3] 李娟, 李杰. 益气扶正、解毒活血、凉补开郁三阶段防治放射性食管炎经验[J]. 环球中医药, 2020, 13(6): 1050-1053.
[4] 李晓东, 曹有军. 放射性食管炎的中医辨证用药规律分析[J]. 中国医药导报, 2019, 16(1): 119-122.
[5] 王苗苗, 汪超, 姚诗清, 等. 清胃散加减治疗急性放射性食管炎的临床研究[J]. 中医临床研究, 2021, 13(24): 97-99.
[6] 陆瑶, 金星, 李栋栋, 等. 关于反流性食管炎中西医治疗研究现况[J]. 新疆中医药, 2022, 40(1): 114-117.
[7] 樊善堃, 李婵娟, 谢艳, 等. 关于“态靶理论”在放射性直肠炎中的运用探讨[J]. 中医药临床杂志, 2025, 37(8): 1503-1507.
[8] 傅骞, 王安, 陈晓莹, 等. 放射线“中药化”基础理论探析[J]. 北京中医药大学学报, 2023, 46(7): 924-930.
[9] 张建鑫. 肺癌放化疗中口服谷氨酰胺预防放射性食管炎的效果[J]. 中国药物经济学, 2023, 18(2): 57-63.
[10] 伏格玛, 周德奇, 罗阔. 增液清热汤联合阿米福汀防治吉西他滨同步大分割三维适形放疗所致的急性放射性食管炎的疗效及对Th1/Th2免疫失衡的影响[J]. 四川中医, 2021, 39(12): 99-102.
[11] 杨从容, 王军, 袁双虎. 放射性食管炎的预防与治疗临床实践指南[J]. 中华肿瘤防治杂志, 2023, 30(6): 324-332.
[12] 黄柳灵. 复合维生素B12漱口液漱服预防控制食管癌放疗患者口干、咽痛、放射性食管炎临床效果观察[J]. 内科, 2020, 15(4): 459-461.
[13] Lu, J., Wang, C., Yang, M., Zhao, H., Liu, Y. and Cao, X. (2014) Effect of Modified Zhuye Shigao Decoction and Its Components on Preventing Radiation Esophagitis of Rats. Chinese Journal of Integrative Medicine, 20, 462-467. [Google Scholar] [CrossRef] [PubMed]
[14] 刘俊德, 全建峰, 沈睿, 等. 沙参麦冬汤对放射性食管损伤患者血清炎性因子及免疫相关性指标的影响[J]. 时珍国医国药, 2020, 31(2): 363-365.